Data shows that during last year's Spring Festival rush, travel among those aged 60 and above surged by nearly 30 percent year on year, with more seniors departing from provinces such as Sichuan, ...
The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.